SCHEMBL30602952

SCHEMBL30602952

C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 4/20 0.59
▸ IL23R Q5VWK5 6/20 0.58
▸ UTS2R Q9UKP6 1/20 0.57
▸ KISS1R Q969F8 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514545 1.00 GHSR (0.59) GHSRIL23RUTS2RKISS1R
SCHEMBL29522651 0.98 GHSR (0.60) GHSRIL23RUTS2RKISS1R
SCHEMBL30979729 0.97 GHSR (0.60) GHSRIL23RUTS2RKISS1R
SCHEMBL30276259 0.97 GHSR (0.60) GHSRIL23RUTS2RKISS1R
SCHEMBL29937863 0.97 GHSR (0.59) GHSRIL23RUTS2RKISS1R
SCHEMBL29938488 0.97 GHSR (0.59) GHSRIL23RUTS2RKISS1R
SCHEMBL29938218 0.96 GHSR (0.58) GHSRIL23RUTS2RKISS1R
SCHEMBL30276223 0.96 IL23R (0.59) GHSRIL23RUTS2RKISS1R
SCHEMBL11206825 0.96 IL23R (0.61) GHSRIL23RUTS2R
SCHEMBL31514537 0.96 IL23R (0.61) GHSRIL23RUTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025043563-A1 PEPTIDE TARGETING SOMATOSTATIN RECEPTOR, DRUG CONJUGATE AND USE THEREOF 主流源生物科技(上海)有限公司 2025-03-06 — — WO claimed
WO-2025043563-A1 PEPTIDE TARGETING SOMATOSTATIN RECEPTOR, DRUG CONJUGATE AND USE THEREOF 主流源生物科技(上海)有限公司 2025-03-06 — — WO disclosed
EP-4514405-A1 COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER ITM Isotope Technologies Munich SE (DE) 2025-03-05 — — EP disclosed
WO-2023208341-A1 COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER ITM Isotope Technologies Munich SE (DE) 2023-11-02 — — WO disclosed
WO-2023209122-A1 COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER ITM Isotope Technologies Munich SE (DE) 2023-11-02 — — WO disclosed
Send feedback